New Cancer Drug Shows Major Promise

A new CAR T cell therapy called satri-cel just helped some late-stage stomach cancer patients live 40% longer in a clinical trial! Basically, doctors supercharged patients’ own immune cells to hunt down cancer, and the results are wild: tumors shrank in 22% of cases (vs just 4% with regular treatment), and people lived months longer on average. There are some side effects, but for folks running out of options, this is a legit breakthrough. Could this be the next big thing in cancer treatment? #CancerBreakthrough #Immunotherapy #HealthNews #Health